Observational studyPloS one2023

Assessing a biomarker's ability to reduce invasive procedures in patients with benign lung nodules: Results from the ORACLE study.

Michael A Pritchett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.